Search results for: Henry Fong
Filter search results
Henry Fong
2 October 2024
Henry joined OHE in October 2024 as a Graduate Economist. He holds an MPharm degree from University College London and is a registered pharmacist with the General Pharmaceutical Council (GPhC)….
Lancelot Henry de Frahan – 2022 Prize Finalist
18 January 2023
Dr. Lancelot Henry de Frahan, PhD, post–doctoral researcher at the Economics department at the University of Chicago. His research specializes in price theory, labor economics and public finance with a…
Biosimilars and Data Exclusivity
8 June 2010
…on the OHE seminar and summarises the remarks of Prof Henry Grabowski of Duke University. Data exclusivity is the period of time after a drug is approved before a biosimilar…
Understanding the Full Value of Long-Acting Therapies: less is more?
7 May 2025
Share this: Download publication Hania El Banhawi Henry Fong Matthias Hofer Lotte Steuten Compared to shorter acting therapies, long-acting therapies might be overlooked and hold potential for patients, healthcare systems…
Taking STRIDES: The Value of Diagnostics Against AMR
10 June 2025
Share this: Download publication Henry Fong George Bray Grace Hampson Lotte Steuten Antimicrobial resistance (AMR) is a global health crisis, projected to cause up to 10 million deaths annually and…
Pharmacogenomics Testing: A Crucial Piece to Unlocking the Full Value of Medicines
5 June 2025
Share this: Henry Fong Chris Sampson Grace Hampson Join us for an online CERSI-PGx Health Economics Workshop on 10 June 2025, from 13:00–17:00 BST, with experts from NHS England, NICE,…
Our team
…Economist Brittany Darrow Graduate Economist Henry Fong Graduate Economist Ellie Tunnicliffe Fellow SooChin Yen Fellow Marketing, Engagement, and Operations Charlotte Ashton-Khan Director of External Affairs Tim Watson Director of Marketing…
New: Priority Review Vouchers and Innovation
17 February 2011
This OHE Seminar Briefing recounts a presentation by Prof Henry Grabowski on US Priority Review Vouchers, intended to provide an incentive for the development of drugs for tropical diseases. One…